Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Authors:
  • MTMarc Tischkowitz
    Marc Tischkowitz
  • HMHelen Mackay
    Helen Mackay
  • KSKenneth Swenerton
    Kenneth Swenerton
  • ARAndré Robidoux
    André Robidoux
  • KTKatia Tonkin
    Katia Tonkin
  • HHHal Hirte
    Hal Hirte
  • DHDavid Huntsman
    David Huntsman
  • MCMark Clemons
    Mark Clemons
  • BGBlake Gilks
    Blake Gilks
  • RYRinat Yerushalmi
    Rinat Yerushalmi
  • EMEuan Macpherson
    Euan Macpherson

Abstract
No abstract available

This publication has 28 references indexed in Scilit: